Moderna

India, EU, US, SA Reach Consensus on Elements of IP Waiver for COVID Vaccines

Who Owns CRISPR? Understanding the Confusion Around This Revolutionary Tech

Amid Omicron Uncertainty, US and Other Countries Secure Borders

‘Govt Must Prioritise Second Jabs for 60+ People and Those With Comorbidities’

Deadlock on Indemnity Clause Keeps US Vaccines From Indian Market

CDC Endorses COVID Booster for Millions of Older Americans, At-Risk People

India Does Not Need COVID Vaccine Booster Doses at This Stage: Experts